|
業務類別
|
Biotechnology |
|
業務概覽
|
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States. |
| 公司地址
| Tuborg Boulevard 12, Hellerup, DNK, 2900 |
| 電話號碼
| +45 70222244 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.ascendispharma.com |
| 員工數量
| 1189 |
| Ms. Aimee Shu |
Executive Vice President and Chief Medical Officer |
-- |
11/02/2026 |
| Dr. Jethro Ekuta, D.V.M.,PhD |
Chief Regulatory and Safety Officer |
-- |
11/02/2026 |
| Mr. Mads Bodenhoff |
Senior Vice President, Head of Finance and Principal Accounting Officer |
-- |
11/02/2026 |
| Mr. Jay Donovan Wu |
Executive Vice President and U.S. President |
-- |
11/02/2026 |
| Ms. Sherrie Glass, M.P.A. |
Chief Business Officer |
-- |
11/02/2026 |
| Mr. Michael Wolff Jensen, L.L.M. |
Executive Vice President and Chief Legal Officer |
-- |
11/02/2026 |
| Mr. Jan Moller Mikkelsen |
President, Chief Executive Officer and Director |
-- |
11/02/2026 |
| Ms. Lotte Sonderbjerg |
Executive Vice President and Chief Administrative Officer |
-- |
11/02/2026 |
| Mr. Flemming Steen Jensen |
Executive Vice President, Product Supply and Quality |
-- |
11/02/2026 |
| Dr. Kennett Sprogoe, PhD |
Executive Vice President and Head of Innovation and Research |
-- |
11/02/2026 |
| Mr. Scott T Smith |
Executive Vice President and Chief Financial Officer |
-- |
11/02/2026 |
| Dr. Stina Singel, M.D.,PhD |
Executive Vice President and Head of Clinical Development, Oncology |
-- |
11/02/2026 |
|
|
| Dr. Albert Cha, M.D.,PhD |
Chairman of the Board |
11/02/2026 |
| Mr. Jan Moller Mikkelsen |
President, Chief Executive Officer and Director |
11/02/2026 |
| Ms. Lisa Bright |
Independent Director |
11/02/2026 |
| Mr. William Carl Fairey, Jr |
Independent Director |
11/02/2026 |
| Mr. Lars Holtug |
Independent Director |
11/02/2026 |
| Ms. Siham Imani |
Independent Director |
11/02/2026 |
|
|
|
|
